Rama Alkhawaldeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rama Alkhawaldeh has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Rana Abu Farha
Faculty of Pharmacy, Applied Science Private University, Amman 11937, Jordan
3 shared publications - Khawla Abu Hammour
The University of Jordan
2 shared publications - Amer Hayat Khan
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau 11700, Penang, Malaysia
1 shared publication - Eman Alefishat
Khalifa University of Science and Technology
1 shared publication - Karem H. Alzoubi
University of Sharjah
1 shared publication - Lobna Gharaibeh
Department of Pharmacy, College of Pharmacy Amman Arab University Amman Jordan
1 shared publication
Latest Publications
- Open Access
- 5 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3196
Exploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study
Objectives: This retrospective analysis was conducted to update the antibiotic sensitivity profiles of Escherichia coli (E. coli) in urinary tract infections (UTIs) among adults (≥18 years) in Jordan. Methods: Data were collected from patients diagnosed with UTIs and confirmed by positive E. coli cultures between 1 January 2019 and 9 July 2021. The resistance patterns of E. coli to empiric antibiotics were assessed by matching the prescribed antibiotics with those tested, using clinical breakpoints to classify isolates as susceptible or resistant. Results: During the study, 230 patients with urine cultures confirming E. coli infection were included. Empiric antibiotics were prescribed to 87.4% (n = 201) of patients. Sensitivity testing was performed for 136 patients (59.1%), revealing that 62 patients (27%) had E. coli strains resistant to at least one antibiotic. Among the 236 empiric antibiotics prescribed, the appropriateness of 72 agents (30.5%) could not be determined owing to the absence of sensitivity testing. The culture results indicate that eight antibiotics (3.3%) did not provide adequate coverage against E. coli. Of the remaining 156 agents (66.1%) subjected to sensitivity testing, 89 (37.7%) were effective, while 67 (28.3%) were ineffective owing to bacterial resistance. Patients who underwent sensitivity tests performed had significantly longer hospital stays (10 days) than those who did not (8 days; p = 0.032). Female patients had a higher proportion of resistant E. coli isolates (51.5%) compared to males (30.8%, p = 0.036). Conclusions: This study highlights the importance of ongoing surveillance to guide empiric therapy and promote appropriate antibiotic use. Tailoring treatment based on patient-specific factors is essential to effectively managing antimicrobial resistance and improving clinical outcomes.
- 5 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3196
Open AccessExploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study
Objectives: This retrospective analysis was conducted to update the antibiotic sensitivity profiles of Escherichia coli (E. coli) in urinary tract infections (UTIs) among adults (≥18 years) in Jordan. Methods: Data were collected from patients diagnosed with UTIs and confirmed by positive E. coli cultures between 1 January 2019 and 9 July 2021. The resistance patterns of E. coli to empiric antibiotics were assessed by matching the prescribed antibiotics with those tested, using clinical breakpoints to classify isolates as susceptible or resistant. Results: During the study, 230 patients with urine cultures confirming E. coli infection were included. Empiric antibiotics were prescribed to 87.4% (n = 201) of patients. Sensitivity testing was performed for 136 patients (59.1%), revealing that 62 patients (27%) had E. coli strains resistant to at least one antibiotic. Among the 236 empiric antibiotics prescribed, the appropriateness of 72 agents (30.5%) could not be determined owing to the absence of sensitivity testing. The culture results indicate that eight antibiotics (3.3%) did not provide adequate coverage against E. coli. Of the remaining 156 agents (66.1%) subjected to sensitivity testing, 89 (37.7%) were effective, while 67 (28.3%) were ineffective owing to bacterial resistance. Patients who underwent sensitivity tests performed had significantly longer hospital stays (10 days) than those who did not (8 days; p = 0.032). Female patients had a higher proportion of resistant E. coli isolates (51.5%) compared to males (30.8%, p = 0.036). Conclusions: This study highlights the importance of ongoing surveillance to guide empiric therapy and promote appropriate antibiotic use. Tailoring treatment based on patient-specific factors is essential to effectively managing antimicrobial resistance and improving clinical outcomes.
- Open Access
- 5 January 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (1) , 41
Public Knowledge and Perceptions about the Emerging Human Mpox in Jordan: A Cross-Sectional Study
Hundreds of human mpox cases are spreading outside of Western and Central Africa, which could be considered a significant world health problem. In this study, we sought to assess public knowledge and perceptions of human mpox. The study was a cross-sectional survey conducted in Jordan in September–October 2022. All participants were approached through social media portals. A total of 1195 participants agreed to participate in this study. The participants showed a low median knowledge score about human mpox (4.0 out of 15.0, IQR = 5.0), with only 27.9% of the participants (n = 334) correctly identifying that human mpox is not a bacterial disease, and around half of them (n = 589, 49.3%) knowing that this disease affects both genders. Higher monthly income (≥400 JD/month) was significantly associated with better knowledge about the disease. Social media was the most comprehensive source of information about mpox (n = 1018, 85.2%). Finally, 57.3% of the participants (n = 685) believed that mpox would affect social and economic life, like the COVID-19 pandemic. These findings highlight the urgent need for systematic strategies that should be promoted to increase public knowledge of mpox, which will be critical in improving the capacity to respond to the disease.
- 5 January 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (1) , 41
Open AccessPublic Knowledge and Perceptions about the Emerging Human Mpox in Jordan: A Cross-Sectional Study
Hundreds of human mpox cases are spreading outside of Western and Central Africa, which could be considered a significant world health problem. In this study, we sought to assess public knowledge and perceptions of human mpox. The study was a cross-sectional survey conducted in Jordan in September–October 2022. All participants were approached through social media portals. A total of 1195 participants agreed to participate in this study. The participants showed a low median knowledge score about human mpox (4.0 out of 15.0, IQR = 5.0), with only 27.9% of the participants (n = 334) correctly identifying that human mpox is not a bacterial disease, and around half of them (n = 589, 49.3%) knowing that this disease affects both genders. Higher monthly income (≥400 JD/month) was significantly associated with better knowledge about the disease. Social media was the most comprehensive source of information about mpox (n = 1018, 85.2%). Finally, 57.3% of the participants (n = 685) believed that mpox would affect social and economic life, like the COVID-19 pandemic. These findings highlight the urgent need for systematic strategies that should be promoted to increase public knowledge of mpox, which will be critical in improving the capacity to respond to the disease.
- Open Access
- 6 May 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (5) , 629
The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study
This is a cross-sectional study that was conducted at Jordan University Hospital (JUH) to evaluate the appropriateness of Urinary Tract Infection (UTI) empiric treatment based on microbial culture data and susceptibility testing. All urine cultures requested for adult patients (≥18 years) admitted to JUH within the period from January 2019–July 2021 were reviewed and only those cultures with positive episodes of infection were considered. In this study, 6950 urine culture episodes were screened; among them, 34.5% (n = 2400) revealed positive results. Among those patients with positive culture episodes, 1600 patients (66.7%) were discharged before the availability of culture results and were excluded. Of the remaining eligible 800 patients, 701 (87.6%) received empiric treatment. In 26.8% of the eligible cases (n = 214), the prescribed empiric agents failed to have appropriate coverage of the identified pathogens, and in 14.6% of the cases (n = 117) the identified microorganisms were reported as resistant to the prescribed empiric agents. Furthermore, only 13.4% of the patients (n = 107) were appropriately treated for their UTI with empiric antibacterial agents. We were not able to judge the appropriateness of UTI treatment for one third (n = 263, 32.9%) of the patients, because they did not have susceptibility reports performed. This study revealed an alarmingly high rate of inappropriate treatment of UTIs, which encourages the emergence of bacterial resistance and affects health-related outcomes negatively. Therefore, antimicrobial stewardship programs must be applied to optimize antibiotic consumption in hospital settings.
- 6 May 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (5) , 629
Open AccessThe Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study
This is a cross-sectional study that was conducted at Jordan University Hospital (JUH) to evaluate the appropriateness of Urinary Tract Infection (UTI) empiric treatment based on microbial culture data and susceptibility testing. All urine cultures requested for adult patients (≥18 years) admitted to JUH within the period from January 2019–July 2021 were reviewed and only those cultures with positive episodes of infection were considered. In this study, 6950 urine culture episodes were screened; among them, 34.5% (n = 2400) revealed positive results. Among those patients with positive culture episodes, 1600 patients (66.7%) were discharged before the availability of culture results and were excluded. Of the remaining eligible 800 patients, 701 (87.6%) received empiric treatment. In 26.8% of the eligible cases (n = 214), the prescribed empiric agents failed to have appropriate coverage of the identified pathogens, and in 14.6% of the cases (n = 117) the identified microorganisms were reported as resistant to the prescribed empiric agents. Furthermore, only 13.4% of the patients (n = 107) were appropriately treated for their UTI with empiric antibacterial agents. We were not able to judge the appropriateness of UTI treatment for one third (n = 263, 32.9%) of the patients, because they did not have susceptibility reports performed. This study revealed an alarmingly high rate of inappropriate treatment of UTIs, which encourages the emergence of bacterial resistance and affects health-related outcomes negatively. Therefore, antimicrobial stewardship programs must be applied to optimize antibiotic consumption in hospital settings.